Dogwood Therapeutics (DWTX) Treasury Shares (2023 - 2026)
Dogwood Therapeutics (DWTX) posted quarterly Treasury Shares of $299128.0 for Q1 2026, little changed year-over-year from $299128.0 in Q1 2025, and little changed quarter-over-quarter from $299128.0 in Q4 2025.
Dogwood Therapeutics (DWTX) Treasury Shares (2023 - 2026) Analysis & Trends
Dogwood Therapeutics (DWTX) has reported Treasury Shares for 4 consecutive years, with $299128.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Treasury Shares changed 0.0% year-over-year to $299128.0; the TTM figure through Mar 2026 stood at $299128.0 (changed 0.0% YoY), while the FY2025 annual figure was $299128.0, changed 0.0% from the prior year.
- Treasury Shares held at $299128.0 in Q1 2026 per DWTX's latest filing, from $299128.0 in the prior quarter.
- Across five years, Treasury Shares topped out at $192951.0 in Q3 2023 and bottomed at $2213.8 in Q4 2024.
- Historically, Treasury Shares has averaged $73271.1 across 4 years, with a median of $7718.0 in 2023.
- On a YoY basis, Treasury Shares climbed as much as 2.35% in 2024 and fell as far as 0.0% in 2024.
- Dogwood Therapeutics' Treasury Shares stood at $299128.0 in 2023, then changed by 0.0% to $299128.0 in 2024, then changed by 0.0% to $299128.0 in 2025, then changed by 0.0% to $299128.0 in 2026.
- Business Quant data shows DWTX's Treasury Shares at $299128.0 in Q1 2026, $299128.0 in Q4 2025, and $299128.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 36.40 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 8.96 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 2.72 Mn |
| 10 | Dogwood Therapeutics | 84.98 Mn | 84.98 Mn | - | 7,718.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 7,718.00 |
| Mar 31, 2026 | 299,128.00 |
| Mar 31, 2026 | 299,128.00 |
| Mar 31, 2026 | 7,718.00 |
| Dec 31, 2025 | 299,128.00 |
| Dec 31, 2025 | 299,128.00 |
| Sep 30, 2025 | 299,128.00 |
| Sep 30, 2025 | 7,718.00 |
| Sep 30, 2025 | 7,718.00 |
| Sep 30, 2025 | 299,128.00 |
| Jun 30, 2025 | 299,128.00 |
| Jun 30, 2025 | 2,269.15 |
| Jun 30, 2025 | 299,128.00 |
| Jun 30, 2025 | 2,269.15 |
| Mar 31, 2025 | 2,213.80 |
| Mar 31, 2025 | 2,213.80 |
| Mar 31, 2025 | 299,128.00 |
| Mar 31, 2025 | 299,128.00 |
| Dec 31, 2024 | 2,213.80 |
| Dec 31, 2024 | 299,128.00 |